UK markets open in 3 hours 29 minutes

HCA Healthcare, Inc. (HCA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
321.89+12.47 (+4.03%)
At close: 04:00PM EDT
321.01 -0.88 (-0.27%)
After hours: 07:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 84.31B
Enterprise value 125.13B
Trailing P/E 16.05
Forward P/E 15.80
PEG ratio (5-yr expected) 1.44
Price/sales (ttm)1.32
Price/book (mrq)N/A
Enterprise value/revenue 1.88
Enterprise value/EBITDA 9.54

Trading information

Stock price history

Beta (5Y monthly) 1.67
52-week change 316.68%
S&P500 52-week change 326.43%
52-week high 3335.83
52-week low 3215.96
50-day moving average 3320.17
200-day moving average 3279.91

Share statistics

Avg vol (3-month) 31.04M
Avg vol (10-day) 31.12M
Shares outstanding 5261.91M
Implied shares outstanding 6264.82M
Float 8188.69M
% held by insiders 127.49%
% held by institutions 165.52%
Shares short (15 Apr 2024) 42.64M
Short ratio (15 Apr 2024) 43.11
Short % of float (15 Apr 2024) 41.36%
Short % of shares outstanding (15 Apr 2024) 41.00%
Shares short (prior month 15 Mar 2024) 42.99M

Dividends & splits

Forward annual dividend rate 42.64
Forward annual dividend yield 40.82%
Trailing annual dividend rate 32.46
Trailing annual dividend yield 30.80%
5-year average dividend yield 40.89
Payout ratio 412.27%
Dividend date 328 Jun 2024
Ex-dividend date 414 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.20%
Operating margin (ttm)14.76%

Management effectiveness

Return on assets (ttm)11.12%
Return on equity (ttm)845.54%

Income statement

Revenue (ttm)66.72B
Revenue per share (ttm)247.75
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)N/A
EBITDA 12.87B
Net income avi to common (ttm)5.47B
Diluted EPS (ttm)20.05
Quarterly earnings growth (yoy)16.70%

Balance sheet

Total cash (mrq)1.38B
Total cash per share (mrq)5.26
Total debt (mrq)42.1B
Total debt/equity (mrq)3,315.20%
Current ratio (mrq)1.16
Book value per share (mrq)-6.14

Cash flow statement

Operating cash flow (ttm)10.1B
Levered free cash flow (ttm)3.78B